Clinical trials
Influenza, Human trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 6 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Unknown status | 2 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 8 |
| Radboud University Medical Center | 3 |
| Hoffmann-La Roche | 2 |
| Maastricht University Medical Center | 2 |
| St. Antonius Hospital | 2 |
| UMC Utrecht | 2 |
| Adamas Pharmaceuticals, Inc. | 1 |
| Alachua Government Services, Inc. | 1 |
| Capital Health, Canada | 1 |
| Crucell Holland BV | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Influenza, Human | 34 |
| Respiratory Tract Infections | 4 |
| Respiratory Tract Diseases | 2 |
| Virus Diseases | 2 |
| Aspergillosis | 1 |
| Atrial Fibrillation | 1 |
| COVID-19 | 1 |
| Community-Acquired Pneumonia | 1 |
| Cough | 1 |
| Fatigue | 1 |
Trials
Showing 51 to 34 of 34. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.